Biotech

All Articles

Pfizer, Valneva reveal lyme disease try reliable for second enhancer

.Pfizer as well as Valneva might have regarding pair of more years to stand by just before they crea...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a talk along with Ayla Ellison, Strong Biotech Managing Editor and also Michelle Ben...

New information demonstrate how Bayer's asundexian failed to prevent strokes

.Bayer suspended the stage 3 test for its aspect XIa prevention asundexian late last year after the ...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stock up as fund shows intent to form its evolution

.Galapagos is happening under added stress from real estate investors. Having actually created a 9.9...

Cell- centered Sana gathers very first CSO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings an...

Allist pays off Jacobio $21M, landing role in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually acquired itself a starring job in China's KRAS market,...

ReNeuron leaving behind purpose swap after overlooking fundraising objective

.ReNeuron has actually joined the lengthy listing of biotechs to leave behind Greater london's goal ...

MBX files for IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has included in the recent outbreak of IPO filings. The biotech, which filed its do...

FDA broadens probe right into Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and the company's would-be MDMA-assisted treatment for trauma (POST-TRAUMATI...